DUBLIN, Feb. 24, 2023 (GLOBE NEWSWIRE) — The Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology), Consumer (Hospital, Diagnostic Laboratory) – Global Forecast to 2030′ was added to ResearchAndMarkets.com’s listing.
The molecular diagnostics market is projected to reach US$46.69 billion by 2030, at a CAGR of 5.6% from 2023 to 2030.
The growth of this market is driven by the increasing geriatric population worldwide, increasing prevalence of communicable and non-communicable diseases, technological advances in molecular diagnostics and rising healthcare expenditures.
However, unfavorable regulatory conditions and the high costs of molecular diagnostic tests are hampering the growth of this market. Growth opportunities in emerging markets, increasing focus on companion diagnostics and rising popularity of direct-to-consumer (DTC) genetic testing are expected to provide growth opportunities for players operating in this market.
Based on product and service, the kits and reagents segment is projected to account for the largest share of the molecular diagnostics market in 2023. The large market share of this segment is attributed to technological advances and the increasing use of diagnostic kits in healthcare.
Based on test type, it is estimated that the laboratory testing segment will account for the largest share of the molecular diagnostics market in 2023. The large market share of this segment is attributed to its advantages, such as: B. Various activities that can be carried out in one room, such as B. Sample processing, diagnosis and further analysis of the results.
Based on the technology, it is estimated that the polymerase chain reaction (PCR) segment will account for the largest share of the molecular diagnostics market in 2023. The large market share of this segment is attributed to the technology’s advantages over others, such as the specific detection of rare DNA sequences with accuracy and the introduction of advanced high-throughput PCR equipment.
Based on application, the infectious diseases segment is estimated to account for the largest share of the molecular diagnostics market in 2023. This segment’s large market share is attributed to the increasing global prevalence of infectious diseases, including hepatitis, HIV, nosocomial infections (HAIs) and influenza. Since these are not age-specific, molecular diagnostics are required for everyone affected by these infectious diseases.
Based on end-users, the hospitals and clinics segment is projected to account for the largest share of the molecular diagnostics market in 2023. The large market share of this segment is attributed to the increase in the number of diagnostic tests performed, especially during the COVID-19 pandemic, increasing technological advances for diagnostic platforms in hospitals and the availability of qualified professionals.
According to estimates, North America will have the largest share of the molecular diagnostics market in 2023, followed by Europe, Asia Pacific, Latin America and the Middle East and Africa. The increase in chronic disease prevalence, the increase in venture capital funding, the increase in healthcare spending and the presence of major companies.
company profiles
F. Hoffmann-La Roche LtdHologic Inc.QIAGEN NVDanaher CorporationbioMerieux SABecton, Dickinson and CompanySiemens Healthineers AGDiaSorin SpAAbbott LaboratoriesThermo Fisher Scientific Inc.Agilent Technologies Inc.Illumina Inc.Seegene Inc. .
Main topics covered:
1 Introduction
2. Research methodology
3. Summary
4. Market Insights
4.1. introduction
4.2. driver
4.2.1. Increasing geriatric population worldwide
4.2.2. Rising prevalence of communicable and non-communicable diseases
4.2.3. Technological advances in molecular diagnostics
4.2.4. Rising healthcare spending
4.3. restrictions
4.3.1. Unfavorable regulatory environment
4.3.2. High cost of molecular diagnostic tests
4.4. occasions
4.4.1. Growing reach in emerging markets
4.4.2. Increasing focus on companion diagnostics
4.4.3. Rising Popularity of Direct-to-Consumer (DTC) Genetic Testing
4.5. challenges
4.5.1. skills shortage
4.6. tendencies
4.6.1. Integration of artificial intelligence and machine learning
4.7. The impact of COVID-19 on the global molecular diagnostics market
5. Price Analysis
6. Global Molecular Diagnostics Market: Regulatory Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Global Molecular Diagnostics Market, By Product and Service
7.1. introduction
7.2. Kits & Reagents
7.3. instruments
7.4. Software & Services
8. Global Molecular Diagnostics Market by Test Type
8.1. introduction
8.2. laboratory tests
8.3. Point of Care (PoC) testing
9. Global Molecular Diagnostics Market by Technology
9.1. introduction
9.2. Polymerase Chain Reaction (PCR)
9.3. In situ hybridization (ISH)
9.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.5. microarrays
9.6. mass spectrometry
9.7. sequencing
9.8. Other Technologies
10. Global Molecular Diagnostics Market by Application
10.1. introduction
10.2. infectious diseases
10.2.1. COVID-19
10.2.2. hepatitis
10.2.3. HIV
10.2.4. Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG)
10.2.5. Human papillomavirus (HPV)
10.2.6. tuberculosis
10.2.7. flu
10.2.8. Healthcare-Associated Infections (HAIs)
10.2.9. Other infectious diseases
10.3. oncology
10.3.1. breast cancer
10.3.2. colon cancer
10.3.3. lung cancer
10.3.4. prostate cancer
10.3.5. lymphoma
10.3.6. leukemia
10.3.7. cervical cancer
10.3.8. Other types of cancer
10.4. genetic test
10.5. neurological diseases
10.6. cardiovascular diseases
10.7. Other Applications
11. Global Molecular Diagnostics Market by End User
11.1. introduction
11.2. Hospitals & Clinics
11.3. diagnostic laboratories
11.4. Academic and research institutes
11.5. Other end users
12. Molecular Diagnostics Market, by Geography
12.1. introduction
12.2. North America
12.2.1. US
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. United Kingdom
12.3.4. Italy
12.3.5. Spain
12.3.6. rest of Europe
12.4. Asia Pacific
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia
12.4.5. Rest of Asia Pacific
12.5. Latin America
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Middle East & Africa
13. Competitive Landscape
13.1. introduction
13.2. key growth strategies
13.3. competitive comparison
13.3.1. Competitive benchmarking by product
13.4. Market share analysis (2022)
For more information about this report, visit https://www.researchandmarkets.com/r/yrtybk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with current data on international and regional markets, key industries, the top companies, new products and the latest trends.
